Cefdinir Dosage and Treatment Duration for Bacterial Infections
Cefdinir is typically dosed at 300 mg twice daily or 600 mg once daily for adults, and 14 mg/kg/day divided into one or two doses for children, with treatment durations ranging from 5-10 days depending on the specific infection. 1
Adult Dosing
Standard Adult Dosing
- 300 mg twice daily or 600 mg once daily, depending on the infection type 1, 2
- Once-daily dosing (600 mg) is appropriate for most respiratory tract infections 3
- Twice-daily dosing (300 mg) is recommended for skin and skin structure infections 1
Duration of Treatment for Adults
- Acute bacterial otitis media: 5-10 days 1
- Acute maxillary sinusitis: 10 days 1, 4
- Pharyngitis/tonsillitis: 5-10 days 1
- Uncomplicated skin and skin structure infections: 10 days 1
- Community-acquired pneumonia: 10 days 3
- Acute bacterial exacerbations of chronic bronchitis: 10 days 3
Pediatric Dosing
Standard Pediatric Dosing (6 months through 12 years)
- Total daily dose: 14 mg/kg/day, up to maximum of 600 mg per day 1
- Can be administered as:
- 7 mg/kg twice daily (every 12 hours) or
- 14 mg/kg once daily (every 24 hours) 1
Duration of Treatment for Children
- Acute bacterial otitis media: 5-10 days (10 days for once-daily dosing) 1
- Acute maxillary sinusitis: 10 days 1
- Pharyngitis/tonsillitis: 5-10 days (10 days for once-daily dosing) 1
- Uncomplicated skin and skin structure infections: 10 days (must use twice-daily dosing) 1
Special Populations
Renal Impairment
- For adults with creatinine clearance <30 mL/min: 300 mg once daily 1
- For pediatric patients with creatinine clearance <30 mL/min/1.73 m²: 7 mg/kg (up to 300 mg) once daily 1
Hemodialysis Patients
- Initial dose: 300 mg or 7 mg/kg every other day 1
- After each hemodialysis session: 300 mg or 7 mg/kg should be administered 1
- Subsequent doses: 300 mg or 7 mg/kg every other day 1
Clinical Efficacy
- Effective against common respiratory pathogens including Haemophilus influenzae, Moraxella catarrhalis, and penicillin-susceptible Streptococcus pneumoniae 2
- Stable against commonly occurring plasmid-mediated beta-lactamases 2
- Shows good distribution into respiratory tissues (sinus, tonsil) and fluids (middle ear) 2, 3
- Clinical and bacteriological efficacy comparable to other oral antibiotics like amoxicillin/clavulanate, cefprozil, and cephalexin in controlled trials 2, 5
Administration Considerations
- May be administered without regard to meals 1
- Oral suspension must be shaken well before each administration 1
- After reconstitution, oral suspension can be stored at room temperature for 10 days 1
- Diarrhea is the most common adverse effect, occurring in approximately 20% of patients 5
Advantages
- Convenient once or twice daily dosing improves compliance 3
- Good option in areas with high rates of beta-lactamase producing organisms 3
- Oral suspension has superior taste compared to many other antibiotic suspensions, improving pediatric compliance 3